These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 32206094)

  • 1. Reactivation of hepatitis B virus infection in rheumatic diseases: risk and management considerations.
    Koutsianas C; Thomas K; Vassilopoulos D
    Ther Adv Musculoskelet Dis; 2020; 12():1759720X20912646. PubMed ID: 32206094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B Reactivation in Rheumatic Diseases: Screening and Prevention.
    Koutsianas C; Thomas K; Vassilopoulos D
    Rheum Dis Clin North Am; 2017 Feb; 43(1):133-149. PubMed ID: 27890170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of HBV reactivation in patients treated with biologic agents.
    Koutsianas C; Thomas K; Vassilopoulos D
    Expert Rev Clin Pharmacol; 2016 Apr; 9(4):579-589. PubMed ID: 26775683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B Virus Reactivation in Rheumatoid Arthritis Patients Undergoing Biologics Treatment.
    Chen MH; Chen MH; Liu CY; Tsai CY; Huang DF; Lin HY; Lee MH; Huang YH
    J Infect Dis; 2017 Feb; 215(4):566-573. PubMed ID: 28011918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B Reactivation During Immunosuppressive Therapy or Cancer Chemotherapy, Management, and Prevention: A Comprehensive Review-Screened.
    Tavakolpour S; Alavian SM; Sali S
    Hepat Mon; 2016 Apr; 16(4):e35810. PubMed ID: 27257429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of hepatitis B virus reactivation in patients with autoimmune diseases undergoing non-tumor necrosis factor-targeted biologics.
    Akiyama S; Cotter TG; Sakuraba A
    World J Gastroenterol; 2021 May; 27(19):2312-2324. PubMed ID: 34040324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rheumatologists' awareness of hepatitis B reactivation before immunosuppressive therapy.
    Toka B; Eminler AT; Gönüllü E; Tozlu M; Uslan MI; Parlak E; Karabay O; Koksal AS
    Rheumatol Int; 2019 Dec; 39(12):2077-2085. PubMed ID: 31520109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of hepatitis B reactivation in patients requiring chemotherapy and immunosuppressive therapy.
    Shih CA; Chen WC
    World J Clin Cases; 2021 Jul; 9(21):5769-5781. PubMed ID: 34368296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B Reactivation: A Review of Clinical Guidelines.
    Wang Y; Han SB
    J Clin Gastroenterol; 2021 May-Jun 01; 55(5):393-399. PubMed ID: 33828065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HBV Reactivation in Patients Undergoing Hematopoietic Stem Cell Transplantation: A Narrative Review.
    Gentile G; Antonelli G
    Viruses; 2019 Nov; 11(11):. PubMed ID: 31717647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapy-Induced Hepatitis B Reactivation Among Patients With Prior Functional Cure: A Systematic Review.
    Bath RM; Doering BE; Nailor MD; Goodlet KJ
    Ann Pharmacother; 2019 Mar; 53(3):294-310. PubMed ID: 30203666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B reactivation in psoriasis patients treated with anti-TNF agents: prevention and management.
    Cannizzaro MV; Franceschini C; Esposito M; Bianchi L; Giunta A
    Psoriasis (Auckl); 2017; 7():35-40. PubMed ID: 29387606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of anti-HBc-positive patients with rheumatic diseases treated with disease-modifying antirheumatic drugs-a single-center analysis of 2054 patients.
    Schwaneck EC; Krone M; Kreissl-Kemmer S; Weißbrich B; Weiss J; Tony HP; Gadeholt O; Schmalzing M; Geier A
    Clin Rheumatol; 2018 Nov; 37(11):2963-2970. PubMed ID: 30238380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B reactivation in the setting of chemotherapy and immunosuppression - prevention is better than cure.
    Pattullo V
    World J Hepatol; 2015 May; 7(7):954-67. PubMed ID: 25954478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of HBV reactivation in non-oncological patients.
    Pisaturo M; Di Caprio G; Calò F; Portunato F; Martini S; Coppola N
    Expert Rev Anti Infect Ther; 2018 Aug; 16(8):611-624. PubMed ID: 30058401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus reactivation in rheumatoid arthritis.
    Wu YL; Ke J; Zhang BY; Zhao D
    World J Clin Cases; 2022 Jan; 10(1):12-22. PubMed ID: 35071501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B Virus Reactivation in the Setting of Immunosuppressive Drug Therapy.
    Su J; Lim JK
    Gastroenterol Hepatol (N Y); 2019 Nov; 15(11):585-592. PubMed ID: 31802984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B in patients with hematological diseases: An update.
    Coluccio C; Begini P; Marzano A; Pellicelli A; Imperatrice B; Anania G; Delle Fave G; Marignani M
    World J Hepatol; 2017 Sep; 9(25):1043-1053. PubMed ID: 28951776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus infection reactivation in patients under immunosuppressive therapies: Pathogenesis, screening, prevention and treatment.
    Spera AM
    World J Virol; 2022 Sep; 11(5):275-282. PubMed ID: 36188738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus reactivation in patients treated with immunosuppressive drugs: a practical guide for clinicians.
    Koffas A; Dolman GE; Kennedy PT
    Clin Med (Lond); 2018 Jun; 18(3):212-218. PubMed ID: 29858430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.